In 2017, the global Opioid-Induced Constipation (OIC) Treatment market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. This report focuses on the global Opioid-Induced Constipation (OIC) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Opioid-Induced Constipation (OIC) Treatment development in United States, Europe and China. The key players covered in this study GlaxoSmithKline AstraZeneca Pfizer S.L.A. Pharma AIKO Biotechnology Cubist Pharmaceuticals Salix Pharmaceuticals Takeda Pharmaceutical Market segment by Type, the product can be split into Oral Parenteral (Subcutaneous Injection) Market segment by Application, split into Drug Store Independent Pharmacies Hospital Pharmacies Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Opioid-Induced Constipation (OIC) Treatment status, future forecast, growth opportunity, key market and key players. To present the Opioid-Induced Constipation (OIC) Treatment development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Opioid-Induced Constipation (OIC) Treatment are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type (2013-2025) 1.4.2 Oral 1.4.3 Parenteral (Subcutaneous Injection) 1.5 Market by Application 1.5.1 Global Opioid-Induced Cons
